SEARCH

SEARCH BY CITATION

References

  • 1
    Andronico G., Piazza G., Mangano MT, Mule G., Carone MB, Cerasola G. Nifedipine vs. enalapril in treatment of hypertensive patients with glucose intolerance. J Curdiovusc Phumiucol 1991; 18 (Suppl 10): S52S54.
  • 2
    Bakris GL, Frohlich ED. The evolution of antihypertensive therapy: an overview of four decades of experience. J Amer Coll Cardiol 1989;14: 15951608.
  • 3
    Cassis LA, Saye J., Peach MJ. Location and regulation of rat angiotensinogen messenger RNA. Hypertension 1988;11: 591596.
  • 4
    Chein KR, Knowlton KU, Zhu H., Chein S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991;5: 30373046.
  • 5
    Dworkin LD, Feiner HD, Parker M., Tolbert E. Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR. Kidney Int 1991;39: 11121117.
  • 6
    Enzi G., Gasparo M., Biondetti PR, Fiore D., Sernisa M., Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computer tomography. Am J Clin Nutr 1986;44: 739746.
  • 7
    Frederich RC, Kahn BB, Peach MJ, Flier FS. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992;19: 339344.
  • 8
    Hennes MMI, McCune SA, Shrago E., Klssebah AH. Synergistic effects of male sex and obesity on hepatic insulin dynamics in SHR/Mcc-cp rat. Diabetes 1990;39: 789795.
  • 9
    Kava RA, West DB, Lukasik VA, Greenwood MRC. Sexual dimorphism of hyperglycemia and glucose tolerance in Wistar fatty rats. Diabetes 1989;38: 159163.
  • 10
    Kissebah AH, Peiris AN. Biology of regional body fat distribution: relationship to non-insulindependent diabetes mellitus. Diabetes/Metabolism Rev 1989;5: 83109.
  • 11
    Kissebah AH, Vydelingum N., Murray R., Evans DJ, Hartz AJ, Kalklioff RK, Adanis PW. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54: 254260.
  • 12
    Lapointe MC, Descheppcr CF, Wu J., Gardner DG. Extracellular calcium regulates expression of the gene for atrial natriuretic factor. Hypertension 1990;15: 2028.
  • 13
    Malaisse WJ, Boscliero AC. Calcium antagonists and islet function XI. Effect of nifedipine. Hormone Res 1977; 8: 203209.
  • 14
    Malaisse WJ, Sener A. Calcium-antagonists and isle function - XII. Comparison between nifedipine and chemically related drugs. Biochem Pharmacol 1981; 30: 10391041.
  • 15
    McCune SA, Baker PB, Stills HF. SHHF/Mcc-cp rat: model of obesity, non-insulin-dependent diabetes, and congestive heart failure. ILAR News 1990;32: 2327.
  • 16
    McCune SA, Jenkins JE, Stills HF, Park S., Radln MJ, Jurin RR, Hamlin RL. Renal and heart function in the SHHF/Mcc-cp rat. In: Frontiers in diabetes research. Lessons from animal diabetes III. Shafrir E., ed.. London: Smith Gordon; 1990: 397401.
  • 17
    Radin MJ, Jenkins JE, McCune SA, Jurin RR, Hanilin RL. Effects of enalapril and clonidine on glomerular structure, function, and atrial natriuretic peptide receptors in SHHF/Mcc-cp rats. J Cardiovasc Pharniacol 1992; 19: 464472.
  • 18
    Reusch JEB, Begum N., Sussman KE, Draznin B. Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinol 1991;129: 32693273.
  • 19
    Rosenzwelg A., Sefdman CE. Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem 1991; 60: 229255.
  • 20
    Russell JC, Koeslag DG, Dolphin PJ, Amy RM. Prevention of myocardial lesion in JCR: LA-corpulent rats by nifedipine. Arteriosclerosis 1990;10: 658664.
  • 21
    Segal S., Lloyd S., Sherman N., Sussnian K., Draznin B. Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes in obesity and non-insulin-dependent diabetes mellitus. Horm Res 1990;34: 3944.
  • 22
    Snedecor GW, Cochran WG. Statistical Methods. 6th ed. The Iowa State University Press, 1967.
  • 23
    Stern MP, Haffner SM. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 1986;6: 123130.
  • 24
    Tuck ML, Bravo EL, Krakoff LR, Friedman CP, and the Modern Approach to the Treatment of Hypertension Study Group. Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients with essential hypertension. Results of a multi-center trial. Am J Hypertens 1990; 3: 333S341S.
  • 25
    Valensi P., Uzzan B., Attali JR, Perret G. Effects of nifedipine and nitrendipine in insulin secretion in obese patients. J Curdiovusc Pharmucol 1991;18(Suppl 1): S91S93.
  • 26
    Weinberger MH. Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk. Am J Med 1986; 80 (suppl 2A): 6470.
  • 27
    Wolpert HA, Steen SN, Istfan NW, Simonson DC. Disparate effects of weight loss on insulin sensitivity and erythrocyte sodium-lithium countertransport activity. Am J Hypertens 1992;5: 754757.
  • 28
    Zawada ET, Saelens DA, Lenibke JM. Influence of calcium infusion on plasma atrial natriuretic peptide in conscious dogs: intervention with calcium antagonist, verapamil. Miner Electrolyte Metab 1990; 16: 369377.